In the last trading session, 54600.0 Mainz Biomed N.V (NASDAQ:MYNZ) shares changed hands as the company’s beta touched 0.13. With the company’s per share price at $4.82 changed hands at -$0.14 or -2.82% during last session, the market valuation stood at $10.27M. MYNZ’s last price was a discount, traded about -929.05% off its 52-week high of $49.60. The share price had its 52-week low at $3.65, which suggests the last value was 24.27% up since then. When we look at Mainz Biomed N.V’s average trading volume, we note the 10-day average is 0.22 million shares, with the 3-month average coming to 119.68K.

Mainz Biomed N.V (NASDAQ:MYNZ) trade information

Instantly MYNZ was in red as seen at the end of in last trading. With action 16.06%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -88.94%, with the 5-day performance at 16.06% in the green. However, in the 30-day time frame, Mainz Biomed N.V (NASDAQ:MYNZ) is -38.19% down. Looking at the short shares, we see there were 87996.0 shares sold at short interest cover period of 0.63 days.

Mainz Biomed N.V (MYNZ) estimates and forecasts

Data shows that the Mainz Biomed N.V share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -67.61% over the past 6 months, a 63.58% in annual growth rate that is considerably higher than the industry average of 16.70%. Year-over-year growth is forecast to reach 19.60% up from the last financial year.

The 2024 estimates are for Mainz Biomed N.V earnings to increase by 63.58%.

MYNZ Dividends

Mainz Biomed N.V is expected to release its next quarterly earnings report in January.

VONTOBEL HOLDING LTD. holds the second largest percentage of outstanding shares, with 0.1181% or 25000.0 shares worth $10025.0 as of 2024-06-30.